The aim of the conference is to present the EESC’s proposal for the new strategy at a crucial moment in the EU landscape. With a new European Commission, a new European Parliament and a new budget programming period, it is now the perfect timing for a new Disability Strategy that fully takes into account the UN Convention on the Rights of Persons with Disabilities (UNCPRD), the Sustainable Development Goals and the 2030 Agenda for Sustainable Development.
From European Public Health Association
Prevention is the foundation of public health policy and central to protecting and improving people’s health and well-being. Europe’s Beating Cancer Plan is a key opportunity to put prevention where it belongs – at the heart of the European Union’s (EU) health agenda.
20 individuals were arrested for cigarette counterfeiting and drug trafficking.
Tackling socially determined inequalities in health, both between and within European Union (EU) Member States, is still a major challenge. This analysis describes the main concepts and gives examples for health inequalities across the EU. It then presents an overview of the work accomplished at international and EU levels. It shows, in particular, how the EU institutions, bodies and agencies have contributed to reducing health inequalities, notwithstanding that Member States have the main responsibility for health policy. The analysis then goes on to depict stakeholder views, before closing with an outlook on avenues for further action.
The EU is co-financing the repatriation of EU citizens from the Diamond Princess cruise ship docked in Yokohama, Japan, thanks to flights from Italy mobilised through the EU Civil Protection Mechanism.
In a meeting held in Brussels last 6th February, the Commission introduced a new project to provide technical assistance to the ERNs for the development, appraisal and implementation of Clinical Practice Guidelines (CPGs) and Clinical Decision Support Tools (CDSTs). This 4 years contract will enable the ERNs to adopt a common methodology and develop their own decision-making tools: 48 new CPGs are expected and 120 existing CPGs will be adapted to the specific rare diseases they are addressing.
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
The Council today adopted conclusions on COVID-19. The conclusions welcome the EU’s effective response to the challenges arising from the outbreak of Novel coronavirus and urge member states to take the necessary measures to enhance their cooperation. They also call on the Commission to examine ways of facilitating member states’ access to personal protective equipment and to evaluate the consequences of global health threats for the availability of medicines within the EU.
By Vaccines Europe
At Vaccines Europe our thoughts are with all those affected by the recent outbreak of the coronavirus (COVID-19). Vaccines Europe, part of the European Federation of Pharmaceutical Industries and Associations (EFPIA), stands in support with the global community and the World Health Organization (WHO) to the current outbreak of COVID-19 acute respiratory disease.
This content was published in the third EU4MD update released on 07.02.2020. This update also presents a section on partnerships and related activities, upcoming events, and a research corner.